EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy

Yang Liu, Xue Xia, Meng Zheng, Bingyang Shi iD

Advanced Materials · 2024

DOI: 10.1002/adma.202314354 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, 2024. Verfasst von Yang Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy and Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, Henan, 475000, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Genetic Therapy, Precision Medicine. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 231 Literaturangaben. Gefördert von: Natural Science Foundation of Henan Province of China, National Health and Medical Research Council, Science and Technology Innovation Talents in Universities of Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is the most burdensome aging‐associated neurodegenerative disorder, and its treatment encounters numerous failures during drug development. Although there are newly approved in‐market β‐amyloid targeting antibody solutions, pathological heterogeneity among patient populations still challenges the treatment outcome. Emerging advances in gene therapies offer opportunities for more precise personalized medicine; while, major obstacles including the pathological heterogeneity among patient populations, the puzzled mechanism for druggable target development, and the precision delivery of functional therapeutic elements across the blood–brain barrier remain and limit the use of gene therapy for central neuronal diseases. Aiming for “precision delivery” challenges, nanomedicine provides versatile platforms that may overcome the targeted delivery challenges for AD gene therapy. In this perspective, to picture a toolbox for AD gene therapy strategy development, the most recent advances from benchtop to clinics are highlighted, possibly available gene therapy targets, tools, and delivery platforms are outlined, their challenges as well as rational design elements are addressed, and perspectives in this promising research field are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGenetic TherapyPrecision MedicineHumansAnimalsNanomedicineBlood-Brain BarrierGene Transfer TechniquesAmyloid beta-PeptidesNanoparticles

Stichwörter der Autor:innen

Alzheimer's diseaseblood–brain barrierdrug deliverygene therapynanoparticles

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Radiotherapy and Translational Medicine Center, Huaihe Hospital of Henan University, Henan University, Kaifeng, Henan, 475000, China.
  • Henan-Macquarie University Joint Centre for Biomedical Innovation, School of Life Sciences, Henan University, Kaifeng, Henan, 475004, China.
  • Macquarie Medical School, Faculty of Medicine & Health Sciences, Macquarie University, Sydney, New South Wales, 2109, Australia.

ORCID-Profile: Bingyang Shi

Förderung

  • Natural Science Foundation of Henan Province of China
  • National Health and Medical Research Council
  • Science and Technology Innovation Talents in Universities of Henan Province
  • Postdoctoral Science Foundation of Jiangsu Province
  • National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Zitieren

APA

Liu, Y., Xia, X., Zheng, M., & Shi, B. (2024). Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy. Advanced Materials. https://doi.org/10.1002/adma.202314354

Vancouver

Liu Y, Xia X, Zheng M, Shi B. Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy. Advanced Materials. 2024. doi:10.1002/adma.202314354

BibTeX
@article{Liu2024,
  author = {Liu, Yang and Xia, Xue and Zheng, Meng and Shi, Bingyang},
  title = {Bio–Nano Toolbox for Precision Alzheimer's Disease Gene Therapy},
  journal = {Advanced Materials},
  year = {2024},
  doi = {10.1002/adma.202314354}
}
Kostenlos starten →